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R185DispatchesCell Cycle: Who Turns the Crank?The oscillating activity of a single CDK–cyclin fusion protein can drive the
orderly progression of yeast cells through DNA replication, mitosis and cell
division.John J. Tyson1 and Bela Novak2
The alternation of DNA synthesis and
mitosis during eukaryotic cell
proliferation is controlled by fluctuating
activities of cyclin-dependent protein
kinases (CDKs). The CDK-based
control system in higher eukaryotes is
a tangled thicket of CDK isoforms,
multiple families of cyclin partners,
regulated transcription factors
and ubiquitin-conjugating enzymes,
stoichiometric inhibitors, and
overlapping layers of phosphorylation
and dephosphorylation. Finding one’s
way through this thicket would be
impossible were it not for the map laid
out by genetic studies of yeast,
pioneered by Hartwell and Nurse [1,2].
Compared with mammalian cells,
the genetics of the fission yeast cell
cycle are quite simple: a single CDK
(encoded by the cdc2 gene; the protein
is called Cdc2) triggers both S phase
(DNA synthesis) and M phase (mitosis)
[3] in association with cyclins Cig2
and Cdc13, respectively. (Two
additional cyclins, Cig1 and Puc1, play
minor roles in G1.) Interestingly, the
cig1, cig2 and puc1 genes can be
deleted (this strain is termed DCCP)
without much effect on the yeast cell’s
ability to control cell-cycle events,
suggesting that a single CDK–cyclin
heterodimeric complex may be
sufficient for orchestrating the DNA
replication–division cycle [4,5].
In a recent paper in Nature, Damien
Coudreuse and Paul Nurse [6] present
some interesting twists on this theme.
They deleted the genes encoding Cdc2
and Cdc13 in the DCCP strain and
integrated into the genome a fused
gene (cdc13–L–cdc2, L is for ‘linker’)
under control of the normal promoter
for cdc13 (this strain is termed
cdc13–L–cdc2 D2 D13 DCCP). The
fused gene expresses a single
polypeptide chain, Cdc13–L–Cdc2,
that folds into an active protein kinase
capable of triggering both S and
M phases with normal kinetics.
Compared with wild-type cells, themutant strain has the same viability,
the same generation time, and nearly
the same size at division. Clearly,
fission yeast cells grow and divide
quite nicely — thank you — without
any help from G1 cyclins or any
mammalian-type rigmarole of
interchanging combinations of CDK
and cyclin subunits.
Not only is the Cdc13–L–Cdc2 fusion
protein sufficient to turn the crank of
normal yeast cell cycles, but it is
also necessary. By introducing
a temperature-sensitive mutation into
the cdc13 component, Coudreuse
and Nurse [6] could arrest cells in G1 or
G2 by shifting them to the restrictive
temperature, and, by introducing
a mutation into the cdc2 component
that renders the kinase sensitive to
the inhibitory effects of the ATP analog
NmPP1, they could arrest cells in G1
or G2 by exposing them to NmPP1.
Although the Coudreuse and Nurse
mutant strain is considerably simpler
(genetically) than wild-type fission
yeast without sacrificing cell-cycle
functions, it still entails multiple levels
of control of the Cdc13–L–Cdc2
construct. The fusion protein is still
subject to: regulated proteolysis
by cyclosome-mediated ubiquitination
of the Cdc13 component [7,8];
inhibition by a stoichiometric binding
partner (Rum1) [9]; and inhibitory
phosphorylation of the Cdc2
component by Wee1 and Mik1 kinases
(opposed by Cdc25 phosphatase) [10].
However, as Coudreuse and Nurse [6]
show, each of these regulatory
pathways can be circumvented. For
example, the rum1 gene can be
deleted from the fusion-protein strain
with no effect on mitotic cycling.
Control by phosphorylation can be
eliminated by mutating the
phosphorylation sites of the Cdc2
component to non-phosphorylatable
amino acids (the cdc2AF mutation).
If this mutation is introduced into
wild-type cells, the mutant strain
is inviable (it enters mitosis before
DNA replication is finished, resultingin a ‘mitotic catastrophe’) [11].
However, when introduced into the
fusion protein, the mutant strain
(cdc13–L–cdc2AF D2 D13 DCCP),
much to everyone’s surprise, is viable.
These cells are the same size as
wild-type cells, although they grow
more slowly and they spin off a small
fraction (5%) of dead progeny.
Control by ubiquitin-mediated
degradation can be eliminated by
removing the ‘degradation box’ (DB)
from the Cdc13 component. When the
cdc13DDB allele is fused with the
analog-sensitive allele of cdc2
(cdc13DDB–L–cdc2as), the mutant
cells are inviable as such, but cycles of
DNA replication and division can be
induced artificially by manipulating the
concentration of NmPP1 in the growth
medium. Cells are blocked in G2 by
1 mMNmPP1. Release into NmPP1-free
medium allows cells to enter mitosis,
but they cannot exit because they
cannot degrade Cdc13DDB–L–Cdc2as.
However, addition of 7.5 mM NmPP1 to
the growth medium allows cells to
complete mitosis, divide and arrest in
G1. Subsequent transfer to 1 mM
NmPP1 allows these cells to replicate
their DNA and arrest in G2, completing
the cycle. Remarkably, these cells
can progress successfully through
the DNA replication–division cycle
with a constantly high level of
Cdc13DDB–L–Cdc2as, provided CDK
activity oscillates with a sufficiently
large amplitude. It must start low
enough to allow ‘licensing’ of DNA for
a new round of replication, then rise to
an intermediate level that is sufficient to
trigger replication of the licensed DNA,
then rise to a higher level necessary to
drive cells into mitosis, and finally CDK
activity must be reduced back to the
low level for cells to exit mitosis, divide
and re-enter G1.
If CDK activity is manipulated in
a different sequence, then the events
of the cell cycle may be induced in
the wrong order. For instance, if
cdc13–L–cdc2as cells are arrested in
G2 with 1 mM NmPP1, then pulsed with
10 mM NmPP1, and then returned to
1 mM NmPP1, they skip M phase, visit
G1 phase briefly, and then are induced
to re-replicate their DNA. If G2-arrested
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Figure 1. How Cdc13–L–Cdc2 turns the cell cycle crank.
(A) Presumptive time course of cyclin-dependent kinase activity, modified from [6]. Red
bar represents the CDK threshold for initiating S phase; blue bar, CDK threshold for initiating
M phase. (B) Mathematical model of the CDK control system, modified from [12]. Black curve
represents the steady-state activity of CDK plotted as a function of the total amount of
Cdc13–L–Cdc2 protein in the cell. L = low state (G1) maintained by the stoichiometric inhibitor
Rum1; I = intermediate state (S/G2) in which Cdc2 is phosphorylated by Wee1 and Mik1; H =
high state (M) in which all Cdc13–L–Cdc2 molecules are active. Green curve represents the
cell-cycle trajectory (see text). (C) Model of the cdc13DDB–L–cdc2as mutant, for different
concentrations of the kinase inhibitor NmPP1 in the growth medium: light gray, 0 mM; medium
grey, 1 mM; dark grey, 10 mM. Observe that the inhibitor pushes the steady state activity curve
to the right in a concentration-dependent manner. Green arrows represent the trajectory of
the DNA replication-division cycle artificially induced by manipulating NmPP1 concentration.
(D) Model of the cdc13–L–cdc2AF mutant, which lacks the intermediate stable steady state.
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G1 by a pulse of 10 mM NmPP1 and
then transferred to NmPP1-free
medium, the cells are driven — by the
rapid rise in CDK activity—directly into
mitosis before DNA replication can be
completed. This experiment clearly
demonstrates a mutual antagonism
between the DNA replication
checkpoint and the CDK activity that
initiatesM phase. If CDK gets the upper
hand, it can inhibit the checkpoint
machinery and induce a mitotic
catastrophe.
From these experiments Coudreuse
and Nurse [6] conclude that the
temporal ordering of cell-cycle events
can be imposed solely by an oscillation
of CDK activity between two extreme
values, as in Figure 1A. Their intuitive
model raises an interesting question: in
the simultaneous presence of S and M
substrates, how can a single CDKactivity trigger the sequential
occurrences of S phase and M phase
instead of an overlapping mess of
DNA replication and mitosis? The most
likely explanation is that CDK
substrates have very different affinities
for the kinase and for the counteracting
protein phosphatases.
In Figure 1B–D, we propose a
theoretical framework for a mechanism
that orders replication and mitosis by
a single CDK [12]. In Figure 1B we plot
CDK activity as a function of the
total amount of fusion protein. The
graph is not a straight line because
of the regulatory proteins that modify
the activity of the fusion protein. In
G1 phase, the total amount of
Cdc13–L–Cdc2 is low because the
protein was thoroughly degraded
as the mother cell exited mitosis and
divided. The activity of the fusion
protein is even lower because G1 cellshave a copious supply of Rum1,
a stoichiometric inhibitor of CDK–cyclin
complexes [13,14]. We can assume
that Rum1 has a very high affinity
for the fusion protein, as it does for
Cdc13–Cdc2 heterodimers [14,15]. As
the cell grows and accumulates more
fusion protein (follow the green curve in
Figure 1B), the CDK activity remains
very low (the L state) until Rum1 is
titrated away andCDKactivity appears.
The first thing that active CDK
molecules do is phosphorylate Rum1
[13], priming Rum1 for degradation
and releasing more fusion proteins
that have been imprisoned by Rum1.
Thereby the CDK control system can
transition to the I state, with
intermediate activity of CDK, where
the fusion protein is hobbled by
phosphorylation of the Cdc2
component. In the I state CDK has
sufficient activity (represented by the
red horizontal line) to overcome the
PPase that has been maintaining DNA
replication-substrates dormant, and
replication starts. When the cell grows
larger and accumulates even more
fusion protein, it eventually reaches the
limit of the stable I state and transitions
to the high steady state (H in Figure 1B).
The high kinase state has sufficient
CDK activity to phosphorylate mitotic
substrates against the more active
mitotic PPases (horizontal blue line). As
the chromosomes come into alignment
on the metaphase plate, the cyclosome
is activated, which ubiquitinates the
Cdc13 component and targets the
fusion protein for rapid degradation
by proteasomes. As the cell exits
mitosis, the amount and the activity
of Cdc13–L–Cdc2 drop along the
diagonal line to the low point in a
newborn cell.
The situation for the mutant fusion
protein with non-degradable Cdc13
is illustrated in Figure 1C. The total
amount of Cdc13DDB–L–Cdc2as is
constantly high, and cells are blocked
in the H state. Although protein level
is high, its activity can be reduced to
a low level by adding 10 mM NmPP1
to the growth medium, inducing cells
to exit mitosis and enter G1.
Subsequent transfer to 1 mM NmPP1
allows cells to exit G1 and enter S/G2.
Finally, transfer to NmPP1-freemedium
allows cells to enter mitosis.
Finally, Figure 1D suggests a way to
think about the non-phosphorylatable
cdc13–L–cdc2AF mutant. The
intermediate steady state is now
missing, and the control systempasses
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R187directly to the upper steady state.
S phase will be initiated as CDK activity
crosses the lower threshold (red bar),
but whether or not the cell is able
to complete the replication of its
DNA before it crosses the upper
threshold (blue bar) and enters mitosis
depends on how fast the fusion protein
is accumulating in the mutant cell. In
a wild-type genetic background, the
Cdc13–Cdc2AF heterodimer
accumulates very quickly, and these
cells enter mitosis with incompletely
replicated DNA, causing a mitotic
catastrophe. But the fusion protein
apparently accumulates more slowly,
giving most cells enough time to finish
DNA replication before the sister
chromatids are pulled apart at
anaphase.
In summary, the cell cycle crank
can be turned, in principle, by a single
cyclin-dependent protein kinase
whose activity fluctuates between
sufficiently low and high values, due to
the influences of regulatory proteins.
The dynamical system creates a series
of switch-like transitions that
guarantee irreversible progressionthrough the classical phases of the
eukaryotic cell cycle.
References
1. Hartwell, L.H. (1978). Cell division from a
genetic perspective. J. Cell Biol. 77, 627–637.
2. Nurse, P. (1991). The Florey Lecture, 1990.
How is the cell division cycle regulated?
Philos. Trans. R. Soc. Lond. B Biol. Sci. 332,
271–276.
3. Nurse, P., and Bissett, Y. (1981). Gene required
in G1 for commitment to cell cycle and in G2 for
control of mitosis in fission yeast. Nature 292,
558–560.
4. Fisher, D.L., and Nurse, P. (1996). A single
fission yeast mitotic cyclin B p34cdc2 kinase
promotes both S-phase and mitosis in
the absence of G1 cyclins. EMBO J. 15,
850–860.
5. Martin-Castellanos, C., Blanco, M.A., de
Prada, J.M., and Moreno, S. (2000). The puc1
cyclin regulates the G1 phase of the fission
yeast cell cycle in response to cell size. Mol.
Biol. Cell 11, 543–554.
6. Coudreuse, D., and Nurse, P. (2010). Driving the
cell cycle with a minimal CDK control network.
Nature 468, 1074–1079.
7. Blanco, M.A., Sanchez-Diaz, A., de Prada, J.M.,
and Moreno, S. (2000). APC(ste9/srw1)
promotes degradation of mitotic cyclins in G(1)
and is inhibited by cdc2 phosphorylation.
EMBO J. 19, 3945–3955.
8. Yamano, H., Gannon, J., and Hunt, T. (1996).
The role of proteolysis in cell cycle progression
in Schizosaccharomyces pombe. EMBO J. 15,
5268–5279.
9. Moreno, S., and Nurse, P. (1994). Regulation of
progression through the G1 phase of the cell
cycle by the rum1+ gene. Nature 367, 236–242.10. Coleman, T.R., and Dunphy, W.G. (1994). Cdc2
regulatory factors. Curr. Opin. Cell Biol. 6,
877–882.
11. Gould, K.L., and Nurse, P. (1989). Tyrosine
phosphorylation of the fission yeast cdc2+
protein kinase regulates entry into mitosis.
Nature 342, 39–45.
12. Tyson, J.J., Csikasz-Nagy, A., and Novak, B.
(2002). The dynamics of cell cycle regulation.
Bioessays 24, 1095–1109.
13. Benito, J., Martin-Castellanos, C., and
Moreno, S. (1998). Regulation of the G1 phase
of the cell cycle by periodic stabilization and
degradation of the p25rum1 CDK inhibitor.
EMBO J. 17, 482–497.
14. Correa-Bordes, J., and Nurse, P. (1995).
p25rum1 orders S phase and mitosis by acting
as an inhibitor of the p34cdc2 mitotic kinase.
Cell 83, 1001–1009.
15. Martin-Castellanos, C., Labib, K., and
Moreno, S. (1996). B-type cyclins regulate
G1 progression in fission yeast in opposition
to the p25rum1 cdk inhibitor. EMBO J. 15,
839–849.
1Department of Biological Sciences,
Virginia Polytechnic Institute & State
University, Blacksburg, VA 24060, USA.
2Oxford Centre for Integrative Systems
Biology, Department of Biochemistry,
Oxford University, Oxford OX1 3QU, UK.
E-mail: tyson@vt.edu, bela.novak@bioch.ox.
ac.ukDOI: 10.1016/j.cub.2011.01.042Structural Colour: Elusive Iridescence
Strategies Brought to LightUnderstanding structural colours in nature requires the right set of optical
experiments: this is illustrated by a new study on iridescent bird of paradise
feathers, which suggests the potential behavioural importance of dynamic
colour changes.Pete Vukusic
The colours of many animals and
some plants are brought about by an
interaction of incident light with
periodic nanostructure. Such effects
are referred to as structural colours
[1,2] and they offer distinct advantages
over pigment-based colour generation
for the control of hue, brightness,
saturation, directionality and
polarisation [2,3]. There has been
keen interdisciplinary interest in
understanding this aspect of biological
systems, in part because of the
emergence of photonics as
a technological field since the 1990s [4]
but also for the insight it offers students
of animal behaviour.The performance and function of
such simpler systems as biological
multilayers are well recognized [2], but
despite recent progress in the use and
development of measurement and
modeling techniques in this area, there
are many other structurally coloured
systems whose detailed action and
function are poorly understood. This is
largely due to the morphological
complexity of their systems’ inherent
photonic structures, which makes it
difficult to discern their role and
effectiveness. Photonic effects arising
from complex system designs are
usually attributed generically to
coherent scattering and their purpose
ascribed generally to conspecific
communication or to camouflage.This is rather too vague, however, and
it invariably overlooks strategic design
features that have key implications in
aspects of display behaviour.
Several factors may contribute to
the complexity of a system. For
instance, it may involve more than one
photonic subsystem of dissimilarly
dimensioned refractive index
periodicities (for example, some
structurally coloured butterfly scales
exhibit both one-dimensional and
three-dimensional periodic structures
[5]). It may also comprise strongly
narrowband or broadband absorbing
pigment that is diffusely or discretely
located within or without an inherent
photonic substructure. And there may
be significant variations about a mean
value of refractive index periodicity,
a biological noise of sorts, which
supplements or complements the
sample’s inherent structural order or
quasi-order. Furthermore, such
periodicity may itself be formed within
an overall geometric envelope that
considerably influences its far-field
optical signature. Achieving
a fundamental grasp of any resulting
